Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 3 (2006), Issue 7 (July)

1. Adjunctive topiramate in ultradian cycling bipolar disorder: case report with 3-year follow-up.
   Eur Psychiatry, 21(4): 280-1. [Abstract] [Full-text]
2. Severe liver enzyme elevations after three years of olanzapine treatment: a case report and review of olanzapine associated hepatotoxicity.
   Prog Neuropsychopharmacol Biol Psychiatry, 30(6): 1163-6. [Abstract] [Full-text]
3. Behavioral effects of short-term administration of lithium and valproic acid in rats.
   Brain Res, 1093(1): 83-94. [Abstract] [Full-text]
4. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
   Prog Neuropsychopharmacol Biol Psychiatry, 30(6): 969-95. [Abstract] [Full-text]
5. The relationship of impulsivity to response inhibition and decision-making in remitted patients with bipolar disorder.
   Eur Psychiatry, 21(4): 270-273. [Abstract] [Full-text]
6. Sustained attention deficits in manic and euthymic patients with bipolar disorder.
   Prog Neuropsychopharmacol Biol Psychiatry, 30(6): 1097-102. [Abstract] [Full-text]
7. Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder.
   Eur Psychiatry, 21(4): 262-9. [Abstract] [Full-text]
8. Prevalence and Diagnostic Correlates of DSM-IV Pathological Gambling in Psychiatric Outpatients.
   J Gambl Stud. [Abstract] [Full-text]
9. Magnetic resonance imaging abnormalities in young euthymic patients with bipolar affective disorder.
   Br J Psychiatry, 189: 81-2. [Abstract] [Full-text]
10. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.
    Br J Psychiatry, 189: 20-5. [Abstract] [Full-text]
11. Exposure to obstetric complications and subsequent development of bipolar disorder: Systematic review.
    Br J Psychiatry, 189: 3-11. [Abstract] [Full-text]
12. Screening psychiatric emergency department patients with major mental illnesses for at-risk drinking.
    Psychiatr Serv, 57(7): 1039-42. [Abstract] [Full-text]
13. Predictors of tobacco use among persons with mental illnesses in a statewide population.
    Psychiatr Serv, 57(7): 1035-8. [Abstract] [Full-text]
14. Diabetes Treatment Among VA Patients With Comorbid Serious Mental Illness.
    Psychiatr Serv, 57(7): 1016-21. [Abstract] [Full-text]
15. Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder.
    Psychiatr Serv, 57(7): 959-65. [Abstract] [Full-text]
16. Collaborative Care for Bipolar Disorder: Part II. Impact on Clinical Outcome, Function, and Costs.
    Psychiatr Serv, 57(7): 937-45. [Abstract] [Full-text]
17. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial.
    Psychiatr Serv, 57(7): 927-36. [Abstract] [Full-text]
18. Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.
    Am J Psychiatry, 163(7): 1199-201. [Abstract] [Full-text]
19. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
    Am J Psychiatry, 163(7): 1179-86. [Abstract] [Full-text]
20. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder.
    Am J Psychiatry, 163(7): 1173-8. [Abstract] [Full-text]
21. Frontal signal hyperintensities in mania in old age.
    Am J Geriatr Psychiatry, 14(7): 598-604. [Abstract] [Full-text]
22. Routine use of the Beck Scale for Suicide Ideation in a psychiatric emergency department.
    Gen Hosp Psychiatry, 28(4): 323-9. [Abstract] [Full-text]
23. Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice.
    Front Neuroendocrinol. [Abstract] [Full-text]
24. Lithium and dementia: a preliminary study.
    Prog Neuropsychopharmacol Biol Psychiatry, 30(6): 1125-8. [Abstract] [Full-text]
25. A continuity between bipolar II depression and major depressive disorder?
    Prog Neuropsychopharmacol Biol Psychiatry, 30(6): 1043-50. [Abstract] [Full-text]
26. Association between obesity and psychiatric disorders in the US adult population.
    Arch Gen Psychiatry, 63(7): 824-30. [Abstract] [Full-text]
27. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.
    Arch Gen Psychiatry, 63(7): 741-7. [Abstract] [Full-text]
28. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure.
    Brain Res, 1097(1): 224-229. [Abstract] [Full-text]
29. Linkage disequilibrium analyses in the Costa Rican population suggests discrete gene loci for schizophrenia at 8p23.1 and 8q13.3.
    Psychiatr Genet, 16(4): 159-68. [Abstract] [Full-text]
30. Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants.
    Psychiatr Genet, 16(4): 153-8. [Abstract] [Full-text]
31. Genetic linkage study for bipolar disorders on chromosomes 17 and 18 in families with a high expression of mental illness from the Balearic Islands.
    Psychiatr Genet, 16(4): 145-51. [Abstract] [Full-text]
32. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.
    Neurosci Lett, 403(3): 288-93. [Abstract] [Full-text]
33. Functional magnetic resonance imaging of executive control in bipolar disorder.
    Neuroreport, 17(11): 1085-9. [Abstract] [Full-text]
34. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Depress Anxiety. [Abstract] [Full-text]
35. Gene expression profiling in schizophrenia and related mental disorders.
    Neuroscientist, 12(4): 349-61. [Abstract] [Full-text]
36. The genetics of depression: a review.
    Biol Psychiatry, 60(2): 84-92. [Abstract] [Full-text]
37. Toward constructing an endophenotype strategy for bipolar disorders.
    Biol Psychiatry, 60(2): 93-105. [Abstract] [Full-text]
38. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis.
    Biol Psychiatry, 60(2): 106-14. [Abstract] [Full-text]
39. The genetics and biology of DISC1--an emerging role in psychosis and cognition.
    Biol Psychiatry, 60(2): 123-31. [Abstract] [Full-text]
40. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats.
    Neuropsychopharmacology, 31(8): 1659-74. [Abstract] [Full-text]
41. Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects.
    Neuropsychopharmacology, 31(8): 1822-31. [Abstract] [Full-text]
42. Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D(2)-like receptor stimulation.
    Psychopharmacology (Berl), 187(3): 303-11. [Abstract] [Full-text]
43. Cognitive function in unaffected twins discordant for affective disorder.
    Psychol Med, 36(8): 1119-29. [Abstract] [Full-text]
44. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia.
    Psychol Med, 36(8): 1085-95. [Abstract] [Full-text]
45. Tiagabine in the maintenance treatment of bipolar disorders.
    Cochrane Database Syst Rev, 3: CD005173. [Abstract] [Full-text]
46. Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability.
    Cochrane Database Syst Rev, 3: CD004694. [Abstract] [Full-text]
47. Haloperidol alone or in combination for acute mania.
    Cochrane Database Syst Rev, 3: CD004362. [Abstract] [Full-text]
48. An open prospective study of zonisamide in acute bipolar depression.
    J Clin Psychopharmacol, 26(4): 385-8. [Abstract] [Full-text]
49. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder.
    J Clin Psychopharmacol, 26(4): 379-84. [Abstract] [Full-text]
50. Cognitive reserve in neuropsychiatry.
    Psychol Med, 36(8): 1053-64. [Abstract] [Full-text]
51. Review of (1)H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis.
    Psychiatry Res, 147(1): 1-25. [Abstract] [Full-text]
52. Sulbutiamine, an 'innocent' over the counter drug, interferes with therapeutic outcome of bipolar disorder.
    World J Biol Psychiatry, 7(3): 183-185. [Abstract] [Full-text]
53. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder.
    Brain Res Bull, 70(3): 221-7. [Abstract] [Full-text]
54. Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease.
    Brain Res, 1103(1): 164-72. [Abstract] [Full-text]
55. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
    Brain Res, 1099(1): 44-55. [Abstract] [Full-text]
56. Child comorbidity, maternal mood disorder, and perceptions of family functioning among bipolar youth.
    J Am Acad Child Adolesc Psychiatry, 45(8): 955-64. [Abstract] [Full-text]
57. Long-term use of atypical antipsychotics in bipolar disorder.
    Pharmacotherapy, 26(8): 1134-47. [Abstract] [Full-text]
58. Anti-heat shock protein 90 is increased in acute mania.
    Aust N Z J Psychiatry, 40(8): 712-6. [Abstract] [Full-text]
59. Reactivity to a laboratory stressor among individuals with bipolar I disorder in full or partial remission.
    J Abnorm Psychol, 115(3): 539-44. [Abstract] [Full-text]
60. Do benzodiazepines extend the duration of follow-up treatment in patients with bipolar disorder?
    Hum Psychopharmacol, 21(5): 319-25. [Abstract] [Full-text]
61. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization.
    Psychiatr Serv, 57(8): 1140-4. [Abstract] [Full-text]
62. Disparities in hospitalization for diabetes among persons with and without co-occurring mental disorders.
    Psychiatr Serv, 57(8): 1126-31. [Abstract] [Full-text]
63. Toward a biaxial model of "bipolar" affective disorders: spectrum phenotypes as the products of neuroelectrical and neurochemical alterations.
    J Affect Disord, 94(1): 15-33. [Abstract] [Full-text]
64. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    J Affect Disord, 94(1): 105-10. [Abstract] [Full-text]
65. Obsessive-compulsive disorder in bipolar disorder patients with first manic episode.
    J Affect Disord, 94(1): 151-6. [Abstract] [Full-text]
66. Are BPI and BPII suicide attempters distinct neuropsychologically?
    J Affect Disord, 94(1): 255-9. [Abstract] [Full-text]
67. Seasonality of admissions for mania in a psychiatric hospital of Belo Horizonte, Brazil.
    J Affect Disord, 94(1): 243-8. [Abstract] [Full-text]
68. Mood disorders in intellectual disability.
    Curr Opin Psychiatry, 19(5): 465-9. [Abstract] [Full-text]
69. SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior.
    Mol Genet Metab, 88(4): 384-8. [Abstract] [Full-text]
70. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder.
    Hum Mol Genet, 15(16): 2438-45. [Abstract] [Full-text]
71. A case of carbamazepine overdose with focal myocarditis.
    Leg Med (Tokyo), 8(4): 243-7. [Abstract] [Full-text]
72. Recognition of emotional facial expressions in attention-deficit hyperactivity disorder.
    Pediatr Neurol, 35(2): 93-7. [Abstract] [Full-text]
73. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Biol Psychiatry, 60(3): 207-17. [Abstract] [Full-text]
74. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder.
    Neurosci Lett, 404(3): 276-81. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.